Porcine Pili Shield (Canada)This page contains information on Porcine Pili Shield for veterinary use.
The information provided typically includes the following:
- Porcine Pili Shield Indications
- Warnings and cautions for Porcine Pili Shield
- Direction and dosage information for Porcine Pili Shield
Porcine Pili ShieldThis treatment applies to the following species:
Escherichia Coli Bacterin
For Use in Animals Only
Porcine Pili Shield Indications
For use in healthy pregnant swine as an aid in the control of disease in piglets caused by K88, K99, 987P, and F41 piliated Escherichia coli.
ADJUVANT: Aluminum hydroxide.
Directions For Use
Shake well before using. Administer 2 mL intramuscularly 5 and 2 weeks prior to farrowing. Revaccinate prior to each subsequent farrowing.
PrecautionsStore out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. It is essential that newborn pigs receive colostrum from the vaccinated dam. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.
U.S. Vet. License No. 303
Novartis Animal Health US, Inc.
©2012 Novartis; Pili Shield is a registered trademark of Novartis AG, used under license.
Novartis Animal Health Canada Inc., Mississauga, Ontario, Canada L5N 1V9
NAC No.: 1231081.4
Distributed by ELANCO, Division Eli Lilly Canada Inc. & ELANCO CANADA LIMITED (successor to Novartis Animal Health Canada Inc.)
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
|Elanco Canada Limited Customer Service Telephone:||800-387-6325|
|Elanco Canada Limited Customer Service Fax:||800-827-5782|
|Every effort has been made to ensure the accuracy of the Porcine Pili Shield information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06